News Novartis AG London S.E.

Equities

0QM7

CH0038459415

Delayed London S.E. Other stock markets 09:29:30 21/05/2018 pm IST			5-day change	1st Jan Change
76.86 ^CHF	-1.00%		-0.77%	-.--%

24/06	Foreign banks target Switzerland after UBS takeover of Credit Suisse	RE
24/06	NOVARTIS AG : Barclays reaffirms its Sell rating	ZD

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Foreign banks target Switzerland after UBS takeover of Credit Suisse	24/06	RE
NOVARTIS AG : Barclays reaffirms its Sell rating	24/06	ZD
INDEX-MONITOR: Tui, Rational and Traton in the MDax - Douglas moves up to the SDax	24/06	DP
Factbox-European companies cut jobs as economy sputters	21/06	RE
Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15	20/06	DP
Novartis: towards the filing of a buyout offer for MorphoSys	20/06	CF
MorphoSys Set to Delist Following Acquisition by Novartis	20/06	MT
MorphoSys Inks Delisting Agreement After Takeover by Novartis	20/06	MT
Biotech company Morphosys will soon disappear from the stock exchange	20/06	RE
EU regulator mandates label updates on CAR-T cancer therapies	14/06	RE
PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment	14/06	MT
Nkarta, Inc. Appoints George Vratsanos as Board of Directors	14/06	CI
Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment	13/06	CI
NOVARTIS AG : JP Morgan reiterates its Neutral rating	11/06	ZD
Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy	07/06	MT
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	07/06	MT
AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation	06/06	MT
Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists	06/06	RE
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	06/06	DJ
Novartis and others face Italy antitrust probe over eye drug	06/06	RE